Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children

The atypical antipsychotic risperidone (RSP) is often associated with weight gain and cardiometabolic side effects. The mechanisms for these adverse events are poorly understood and, undoubtedly, multifactorial in etiology. In light of growing evidence implicating the gut microbiome in the host'...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahr, S M, Tyler, B C, Wooldridge, N, Butcher, B D, Burns, T L, Teesch, L M, Oltman, C L, Azcarate-Peril, M A, Kirby, J R, Calarge, C A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930121/
https://www.ncbi.nlm.nih.gov/pubmed/26440540
http://dx.doi.org/10.1038/tp.2015.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930121/
https://www.ncbi.nlm.nih.gov/pubmed/26440540
http://dx.doi.org/10.1038/tp.2015.135

Ejemplares similares